Latest filing published 06 Aug 2026 for Immunome, Inc., €2.4M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Abhmc II, LLC: trading record in brief
Abhmc II, LLC appears in our data through filings on Immunome Inc. shares, published by SEC (Form 4). Between 30 June 2026 and 6 August 2026, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 6 August 2026, the filings show a transaction worth €2.4M in Immunome Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Abhmc II, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 108,504 shares@ US$25.52CommonSEC144:0001628280-26-054494
- 100,000 shares@ US$23.6152.3% of flowCommonSEC144:0001628280-26-047387
- 100,000 shares@ US$21.49100.0% of flowCommonSEC144:0001628280-26-046982
- 100,000 shares@ US$21.0431.8% of flowCommonSEC144:0001628280-26-046298
4 of 4 declarations
